who cannot take glp-1 medications may not work well for a significant portion of the population, a Stanford Medicine researcher and her colleagues found. Genetic testing could help patients get on the right drugs faster What Is GLP-1 and Why

Lifestyle Factors: Obesity, prolonged inactivity, and a sedentary lifestyle are key risk factors for developing blood clots

Gastroenterology (2013) 145(5):104554

Visit the Mayo Clinic News Network for additional Mayo Clinic news

doi: 10.3748/wjg.v20.i40.14821 54 WangYParlevlietETGeerlingJJvan der TuinSJZhangHBieghsVet al

Epithalon is a peptide recognized for its potential impact on telomerase production, offering avenues for studying cellular aging processes

Long-Acting GLP-1 Receptor Agonists Designed for once-weekly use, long-acting formulations maintain a more consistent presence in the bloodstream , providing steady appetite regulation and improved insulin sensitivity throughout the week